Arena Pharmaceuticals

$65.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+0.17%) Today

$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ARNA and other stocks, options, and ETFs commission-free!

About ARNA

Arena Pharmaceuticals, Inc. Common Stock, also called Arena Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA. The listed name for ARNA is Arena Pharmaceuticals, Inc. Common Stock.

CEO

Amit Dilip Munshi

Employees

320

Headquarters

San Diego, California

Founded

1997

Market Cap

3.81B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.35M

High Today

$66.98

Low Today

$65.00

Open Price

$65.33

Volume

396.52K

52 Week High

$90.19

52 Week Low

$32.95

Collections

Analyst Ratings

100%

of 13 ratings

Buy

100%

Hold

Sell

ARNA Earnings

-$2.28

$3.11

$8.50

$13.89

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 24, After Hours